In a time of increasingly bespoke healthcare, Elizabeth Philp has emerged as a formidable force of innovation, particularly in the tech-driven field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the forefront of a movement to make bespoke medications more obtainable, questioning the standard one-size-fi